{
  "docId": "019de076-9336-7344-93bc-154185328b25",
  "docSlug": "edea36d6b00ed662cafb2da1a03c41ae",
  "documentTitle": "BenevolentAI | Investor Conference Presentation Deck | 22 slides",
  "authorId": "benevolentai",
  "authorName": "BenevolentAI",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2024-01-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 3,
  "pageCount": 22,
  "prevPage": 2,
  "nextPage": 4,
  "slideType": "revenue_buildup",
  "function": "present_solution",
  "density": "dense",
  "nDataPoints": 1,
  "notes": "The slide uses a three-column layout to categorize revenue streams: Drug Discovery (yellow), Development Pipeline (orange), and Knowledge Exploration Tools (teal).",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-9336-7344-93bc-154185328b25/3",
  "deckHref": "/decks/019de076-9336-7344-93bc-154185328b25",
  "deckJsonHref": "/decks/019de076-9336-7344-93bc-154185328b25.json",
  "deckAnchorHref": "/decks/019de076-9336-7344-93bc-154185328b25#slide-3",
  "components": [
    {
      "bbox": {
        "h": 0.08,
        "w": 0.9,
        "x": 0.05,
        "y": 0.15
      },
      "kind": "callout",
      "text": "Benevolent Platform™: A versatile, scalable and robust AI-enabled drug discovery platform built with expert scientists, leveraging multi-modal data foundations",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7d3e6d03-b86b-4df4-ae36-21f9c04e448b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.5,
        "w": 0.3,
        "x": 0.67,
        "y": 0.35
      },
      "kind": "list",
      "text": "Knowledge Exploration Tools: Suite of AI products (BenAI-Q, BenAI Research Assistant), building from core technologies. Highly scalable, recurring revenue: Fees for Setup, licenses & seats + support.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "726967c2-5eaf-47e4-ac42-4387367d2eca",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.5,
        "w": 0.3,
        "x": 0.05,
        "y": 0.35
      },
      "kind": "list",
      "text": "End-to-End Drug Discovery: Platform enables novel discoveries, industry-leading collaborations, validated by AstraZeneca and Merck. High value collaborations: Upfront payments + milestones + royalties.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "aba828fa-6f52-4a03-be39-5f035e24d512",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.5,
        "w": 0.3,
        "x": 0.36,
        "y": 0.35
      },
      "kind": "list",
      "text": "Preclinical & Clinical Development Pipeline: 5 high potential assets, first-in-class/best-in-class, progressing to inflection points. Mid-long term value creation: Upfront fees + milestones + royalties.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f8edaf4f-dcca-4f2c-af05-c0e7d1a58e3b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.9,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "Benevolent Platform™ drives our three revenue streams",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5688a4d9-3843-4cb1-a3e9-f75d0edadd48",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 4,
      "from": 3,
      "beatId": "1bdb0d36-4050-42a3-8831-93c025083457",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Problem",
      "beatSlug": "sequoia-pitch-problem",
      "evidence": "The presentation starts by introducing the Benevolent Platform™ and its revenue streams.",
      "position": 0,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [
    {
      "to": 9,
      "from": 3,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "0a7dc950-f012-4806-a974-ccc12cfbaec1",
      "evidence": "The presentation emphasizes the potential of the Benevolent Platform™.",
      "position": 0,
      "objective": "Highlighting the importance of AI-driven drug discovery",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}